We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 2,264 results
  1. Bullöse Autoimmundermatosen der Schleimhaut

    Autoimmune bullous diseases (AIBD) comprise a group of organ-specific autoimmune diseases which are characterised by the production of autoantibodies...

    Dario Didona, Julia Hinterseher, Rüdiger Eming in Die Dermatologie
    Article 25 August 2022
  2. Application of topical gentamicin—a new era in the treatment of genodermatosis

    Background

    The clinical use of gentamicin always lies in its antimicrobial activity in the past as an aminoglycoside antibiotic. However, in the past...

    Shan Wang, Zhou Yang, ... Yong-Hong Yang in World Journal of Pediatrics
    Article 17 November 2021
  3. Roles of dystonin isoforms in the maintenance of neural, muscle, and cutaneous tissues

    Dystonin ( DST ), also known as bullous pemphigoid antigen 1 ( BPAG1 ), encodes cytoskeletal linker proteins belonging to the plakin family. The DST gene...

    Article 21 August 2023
  4. Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale

    Background

    Epidermolysis bullosa (EB) is a group of rare, genetic diseases that affect the integrity of epithelial tissues, most notably the skin....

    Johannes S. Kern, Agnes Schwieger-Briel, ... Anna E. Martinez in Trials
    Article Open access 11 June 2019
  5. Psychosocial recommendations for the care of children and adults with epidermolysis bullosa and their family: evidence based guidelines

    Epidermolysis Bullosa (EB) is a group of rare genetic disorders resulting in skin fragility and other symptoms. Commissioned by DEBRA International...

    K. Martin, S. Geuens, ... K. M. Mayre-Chilton in Orphanet Journal of Rare Diseases
    Article Open access 11 June 2019
  6. Multiple drugs

    Article 19 August 2023
  7. Multiple drugs

    Article 25 May 2024
  8. Bullöse Autoimmundermatosen

    Silke C. Hofmann, Miklós Sárdy in Die Dermatologie
    Article 20 November 2023
  9. Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years’ experience of a reference centre in Spain

    Background

    Cutaneous squamous cell carcinoma (cSCC) is the leading cause of death in patients with recessive dystrophic epidermolysis bullosa (RDEB)....

    B. Castelo, D. Viñal, ... R. de Lucas in Clinical and Translational Oncology
    Article 12 March 2019
  10. Junctional Epidermolysis Bullosa in a Neonate

    Santhiya Srinivasan, Indar Kumar Sharawat, ... Ak Mahapatra in Indian Pediatrics
    Article 29 December 2018
  11. Atezolizumab

    Article 01 June 2024
  12. Vitamin-E

    Article 04 May 2024
  13. Composite endpoints, including patient reported outcomes, in rare diseases

    Background

    When assessing the efficacy of a treatment in any clinical trial, it is recommended by the International Conference on Harmonisation to...

    Johan Verbeeck, Maya Dirani, ... Rima Nabbout in Orphanet Journal of Rare Diseases
    Article Open access 01 September 2023
  14. Development of the PROMIS pediatric stigma and extension to the PROMIS pediatric stigma: skin item banks

    Purpose

    To develop the PROMIS Pediatric Stigma (PPS) and Skin (PPS-Skin) by constructing a common metric for measuring stigma in children with various...

    **-Shei Lai, Cindy Nowinski, ... Amy S. Paller in Quality of Life Research
    Article 03 January 2024
  15. Carer burden in rare inherited diseases: a literature review and conceptual model

    Background

    Carers of people living with rare diseases report heavy burden and a plethora of unmet needs. A previous parental supportive care needs...

    Kerry Sandilands, Angela Williams, Angela J. Rylands in Orphanet Journal of Rare Diseases
    Article Open access 09 December 2022
  16. Multiple drugs

    Article 05 August 2023
  17. Management von bullösem Pemphigoid und Schleimhautpemphigoid

    Background

    Bullous pemphigoid (BP) is the most common blistering autoimmune dermatosis and, as an age-associated disease, is also the bullous...

    Johannes S. Kern, Silke C. Hofmann in Die Dermatologie
    Article 16 October 2023
Did you find what you were looking for? Share feedback.